Mongraw-Chaffin Morgana, Saldana Santiago, Carnethon Mercedes R, Chen Haiying, Effoe Valery, Golden Sherita Hill, Joseph Joshua, Kalyani Rita R, Bertoni Alain G
Department of Epidemiology & Prevention, Wake Forest School of Medicine, Winston-Salem NC, USA.
Department of Biostatistics and Data Science, Wake Forest School of Medicine, Winston-Salem NC, USA.
J Endocr Soc. 2022 Apr 9;6(6):bvac059. doi: 10.1210/jendso/bvac059. eCollection 2022 Jun 1.
Multiple studies suggest that adults who were normal weight at diabetes diagnosis are at higher risk for all-cause mortality than those who had overweight or obesity at diagnosis.
While obesity is a known risk factor for cardiometabolic disease, differences in body fat distribution in those without obesity are understudied, especially in African Americans.
In 1005 participants of the Jackson Heart Study, without cardiovascular disease at baseline, we used logistic regression to investigate the longitudinal association of body fat distribution by CT scan with metabolic syndrome (MetS) or type 2 diabetes (T2D). We used the harmonized International Diabetes Federation criteria to define MetS. We included only normal weight or overweight participants (BMI: 18.5 to < 30.0 kg/m). We created separate models for MetS and T2D adjusted for a standard set of covariates. We excluded participants with prevalent MetS or T2D, respectively in sensitivity.
Higher visceral fat, subcutaneous fat, BMI, and insulin resistance (HOMA-IR) were significantly associated with MetS and T2D after adjustment. Visceral fat was strongly associated with both outcomes (MetS OR = 2.07 [1.66-2.68]; T2D OR = 1.51 [1.21-1.88]), and the association for MetS persisted in the normal weight only group. Estimates were robust to sensitivity analysis and were only modestly mediated by insulin resistance. Physical activity was not associated with MetS or T2D.
Visceral fat is strongly associated with developing MetS, even in normal weight individuals, suggesting that excess visceral fat plays a role in cardiometabolic risk beyond that of overall adiposity and obesity in African Americans.
多项研究表明,糖尿病诊断时体重正常的成年人比诊断时超重或肥胖的成年人全因死亡率更高。
虽然肥胖是已知的心血管代谢疾病风险因素,但对于非肥胖人群体脂分布的差异研究较少,尤其是非裔美国人。
在杰克逊心脏研究的1005名参与者中,这些参与者基线时无心血管疾病,我们使用逻辑回归研究通过CT扫描测量的体脂分布与代谢综合征(MetS)或2型糖尿病(T2D)之间的纵向关联。我们使用统一的国际糖尿病联盟标准来定义MetS。我们仅纳入体重正常或超重的参与者(BMI:18.5至<30.0kg/m²)。我们分别为MetS和T2D创建了调整了一组标准协变量的单独模型。在敏感性分析中,我们分别排除了患有现患MetS或T2D的参与者。
调整后,较高的内脏脂肪、皮下脂肪、BMI和胰岛素抵抗(HOMA-IR)与MetS和T2D显著相关。内脏脂肪与这两种结局均密切相关(MetS比值比=2.07[1.66 - 2.68];T2D比值比=1.51[1.21 - 1.88]),并且MetS的关联在仅体重正常的组中持续存在。估计值对敏感性分析具有稳健性,并且仅由胰岛素抵抗适度介导。身体活动与MetS或T2D无关。
即使在体重正常的个体中,内脏脂肪也与MetS的发生密切相关,这表明在非裔美国人中,内脏脂肪过多在心血管代谢风险中所起的作用超出了总体肥胖的影响。